Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 5 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
Zverev drops 1st set, rallies to win Aussie opener
- 5 گھنٹے قبل
Can the right diet really cure all our health problems?
- 4 گھنٹے قبل
Blast reported at peace committee member’s residence in KP’s DI Khan
- 11 گھنٹے قبل
The Supreme Court is likely to hand Trump a rare loss on the Federal Reserve
- 4 گھنٹے قبل
Netflix revises Warner Bros. bid to an all-cash offer
- 6 گھنٹے قبل
Why expensive airline “premiums” don’t feel special at all
- 4 گھنٹے قبل
Australian Open: Raducanu hits out at schedule
- 5 گھنٹے قبل
Can America build beautiful places again?
- 4 گھنٹے قبل
Animal Crossing: New Horizons added just enough to suck me back in
- 6 گھنٹے قبل
Djokovic: Pursuit of 25th major not 'now or never'
- 5 گھنٹے قبل
“Trump always chickens out,” briefly explained
- 4 گھنٹے قبل
A second US Sphere could come to Maryland
- 6 گھنٹے قبل
You May Like
Trending
